For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Tablet splitting generally ok; some exceptions
Wednesday 27 March 2024, 12:28 AM

[Image: Towfiqu barbhuiya on Unsplash]
Goodfellow Gems #213
A 2022 review of tablet splitting notes: “With the exception of sustained-release tablets, which should not be split, and excepting those older people
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
doi.org/10.3399/BJGPO.2022.0001 (BJGP Open 2022;6[3]).